In the past week, CNMD stock has gone down by -1.64%, with a monthly decline of -5.09% and a quarterly surge of 3.38%. The volatility ratio for the week is 3.82%, and the volatility levels for the last 30 days are 3.77% for Conmed Corp The simple moving average for the past 20 days is -1.67% for CNMD’s stock, with a -4.43% simple moving average for the past 200 days.
Is It Worth Investing in Conmed Corp (NYSE: CNMD) Right Now?
The price-to-earnings ratio for Conmed Corp (NYSE: CNMD) is above average at 16.05x, Company’s 36-month beta value is 1.47.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 3 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for CNMD is 30.03M, and currently, short sellers hold a 7.91% ratio of that floaft. The average trading volume of CNMD on January 20, 2025 was 408.62K shares.
CNMD) stock’s latest price update
Conmed Corp (NYSE: CNMD)’s stock price has soared by 1.24 in relation to previous closing price of 66.86. Nevertheless, the company has seen a loss of -1.64% in its stock price over the last five trading days. zacks.com reported 2025-01-08 that Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Analysts’ Opinion of CNMD
Many brokerage firms have already submitted their reports for CNMD stocks, with Needham repeating the rating for CNMD by listing it as a “Buy.” The predicted price for CNMD in the upcoming period, according to Needham is $129 based on the research report published on February 01, 2024 of the previous year 2024.
CL King, on the other hand, stated in their research note that they expect to see CNMD reach a price target of $140. The rating they have provided for CNMD stocks is “Buy” according to the report published on May 22nd, 2023.
KeyBanc Capital Markets gave a rating of “Overweight” to CNMD, setting the target price at $124 in the report published on March 27th of the previous year.
CNMD Trading at -5.51% from the 50-Day Moving Average
After a stumble in the market that brought CNMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -38.88% of loss for the given period.
Volatility was left at 3.77%, however, over the last 30 days, the volatility rate increased by 3.82%, as shares sank -4.97% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -3.94% lower at present.
During the last 5 trading sessions, CNMD fell by -1.64%, which changed the moving average for the period of 200-days by -12.66% in comparison to the 20-day moving average, which settled at $68.84. In addition, Conmed Corp saw -1.10% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CNMD starting from Hartman Curt R, who proposed sale 2,849 shares at the price of $74.84 back on Nov 08 ’24. After this action, Hartman Curt R now owns shares of Conmed Corp, valued at $213,219 using the latest closing price.
Peters Stanley W III, the Officer of Conmed Corp, proposed sale 2,171 shares at $72.40 during a trade that took place back on Aug 27 ’24, which means that Peters Stanley W III is holding shares at $157,181 based on the most recent closing price.
Stock Fundamentals for CNMD
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.54 for the gross margin
The net margin for Conmed Corp stands at 0.1. The total capital return value is set at 0.09. Equity return is now at value 15.24, with 5.68 for asset returns.
Based on Conmed Corp (CNMD), the company’s capital structure generated 0.5 points at debt to capital in total, while cash flow to debt ratio is standing at 0.19. The debt to equity ratio resting at 1.01. The interest coverage ratio of the stock is 4.96.
Currently, EBITDA for the company is 192.48 million with net debt to EBITDA at 3.66. When we switch over and look at the enterprise to sales, we see a ratio of 2.33. The receivables turnover for the company is 5.56for trailing twelve months and the total asset turnover is 0.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.27.
Conclusion
In a nutshell, Conmed Corp (CNMD) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
